Pathologic Classification Systems in MS: What is their Significance?

Barnett MH , Prineas JW. Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion . Ann Neurol 2004; 55: 458-468 .

Bjartmar C , Trapp BD. Axonal and neuronal degeneration in multiple sclerosis: Mechanisms and functional consequences . Curr Opin Neurol 2001; 14: 271-278 .

Bo L , Nyland H , Trapp BD , Mork S. Cortical demyelination in multiple sclerosis . J Neuropathol Exp Neurol 2000; 59: 431-431 .

Davie CA , Silver NC , Barker GJ , Tofts P , Thompson AJ , McDonald WI , Miller DH. Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup? J Neurol Neurosurg Psychiatry 1999; 67: 710-715 .

Evangelou N , Konz D , Esiri MM , Smith S , Palace J , Matthews PM. Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis . Brain 2001; 124: 1813-1820 .

Lassmann H. Classification of demyelinating diseases at the interface between etiology and pathogenesis . Curr Opin Neurol 2002; 14: 253-258 .

Lucchinetti C , Bruck W , Noseworthy J. Multiple sclerosis: Recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment . Curr Opin Neurol 2001; 14: 259-269 .

Ludwin SK. Understanding multiple sclerosis: Lessons from pathology . Ann Neurol 2000; 47: 691-693 .

Matthews PM , Arnold DL. Magnetic resonance imaging of multiple sclerosis: New insights linking pathology to clinical evolution . Curr Opin Neurol 2001; 14: 279-287 .

Van der Valk P , De Groot CJ. Staging of multiple sclerosis lesions: Pathology of the time frame of MS . Neuropathol Appl Neurobiol 2000; 26: 2-10 .